Page last updated: 2024-09-05

tunicamine and Multiple Myeloma

tunicamine has been researched along with Multiple Myeloma in 1 studies

*Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. [MeSH]

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dickson, AJ; Lengwehasatit, I	1

Other Studies

1 other study(ies) available for tunicamine and Multiple Myeloma

Article	Year
Analysis of the role of GADD153 in the control of apoptosis in NS0 myeloma cells. Biotechnology and bioengineering, 2002, Dec-30, Volume: 80, Issue:7 Topics: Apoptosis; CCAAT-Enhancer-Binding Proteins; Cell Count; Cell Survival; Culture Media; Disaccharides; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Galactosamine; Glucose; Glutamine; Multiple Myeloma; Reproducibility of Results; Sensitivity and Specificity; Transcription Factor CHOP; Transcription Factors; Tumor Cells, Cultured	2002

Article

Year

Analysis of the role of GADD153 in the control of apoptosis in NS0 myeloma cells.

Biotechnology and bioengineering, 2002, Dec-30, Volume: 80, Issue:7

Topics: Apoptosis; CCAAT-Enhancer-Binding Proteins; Cell Count; Cell Survival; Culture Media; Disaccharides; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Galactosamine; Glucose; Glutamine; Multiple Myeloma; Reproducibility of Results; Sensitivity and Specificity; Transcription Factor CHOP; Transcription Factors; Tumor Cells, Cultured

2002